A Randomized, Double-Blind, Double-Dummy, Active-Control

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients with Primary Hypercholesterolemia Who are Intolerant to Statins
StatusFinished
Effective start/end date1/29/139/30/17

Funding

  • Regeneron Pharmaceuticals, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.